跳至主要内容
临床试验/NCT02204709
NCT02204709终止不适用

Disease Risk Reduction and n-3 Rich Rainbow Trout (Fish for Health)

USDA Grand Forks Human Nutrition Research Center1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2015年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
29
试验地点
1
主要终点
Change from baseline in platelet activation at week 6 of each treatment

研究概览

简要总结

The purpose of this study is to determine how eating fish raised to have different levels of omega-3 fatty acids will reduce cardiovascular risk markers in people with elevated cardiovascular risk.

详细描述

Consumption of fish high in long chain omega-3 fatty acids (LCn3) is associated with reduction of cardiovascular disease (CVD) risk. CVD is a major cause of death in the United States. The current obesity epidemic contributes significantly to elevated CVD risk by increasing inflammation and platelet dysfunction. Prevention of CVD is a public health goal and comprises several avenues of action, of which inclusion of LCn3-rich fish in the diet may be one of the most effective.

Obese participants will participate in a double blind, randomized, cross-over designed trial in which they will consume twice-weekly a prepared meal containing diploid (2N) farmed rainbow trout, triploid (3N) farmed rainbow trout containing higher levels of LCn3, or tilapia, a low LCn3 fish.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •BMI of 30 - 39.9 kg/m2

排除标准

  • •Are allergic to fish
  • •Use tobacco products or nicotine in any form including snuff, pills, and patches, or e-cigarettes in the past 6 months
  • •Have established cardiovascular, pulmonary, and/or a metabolic disease such as diabetes
  • •Have uncontrolled high blood pressure
  • •Have alcohol, anabolic steroids, or other substance abuse issues
  • •Consume more than 3 alcoholic drinks/week
  • •Have cancer
  • •Are pregnant or nursing
  • •Take non-steroidal anti-inflammatory drugs such as aspirin, ibuprofen or Aleve, lipid modifying drugs such as statins, take medications for blood glucose such as insulin or metformin

研究组 & 干预措施

Diploid Trout entrees

Experimental

Subjects will consume a 200 gram portion of 2N trout (diploid; two sets of chromosomes) twice weekly in a prepared meal.

干预措施: 2N Trout (Other)

Triploid Trout entrees

Experimental

Subjects will consume a 200 gram portion of 3N trout (triploid; three sets of chromosomes) twice weekly in a prepared meal.

干预措施: 3N Trout (Other)

Tilapia entrees

Experimental

Subjects will consume a 200 gram portion of tilapia twice weekly in a prepared meal.

干预措施: Tilapia (Other)

结局指标

主要结局

Change from baseline in platelet activation at week 6 of each treatment

时间窗: Baseline, Week 6

次要结局

  • Change from baseline in serum thromboxane B2 (TxB2) at week 6 of each treatment(Baseline, Week 6)
  • Change from baseline in plasma phospholipid fatty acids at week 6 of each treatment(Baseline, Week 6)
  • Change from baseline in plasma interleukin-6 (IL-6) at week 6 of each treatment(Baseline, Week 6)
  • Change from baseline in plasma tumor necrosis factor alpha (TNFa) at week 6 of each treatment(Baseline, Week 6)
  • Change from baseline in urinary thromboxane B2 (TxB2-M) at week 6 of each treatment(Baseline, Week 6)
  • Change from baseline in platelet fatty acids at week 6 of each treatment(Baseline, Week 6)
  • Change from baseline in urinary prostaglandin E2 (PGE2) at week 6 of each treatment(Baseline, Week 6)
  • Change from baseline in urinary prostaglandin I2 (PGI2-M) at week 6 of each treatment(Baseline, Week 6)

研究者

发起方
USDA Grand Forks Human Nutrition Research Center
申办方类型
Fed
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验